Studies of comparative mRNA booster effectiveness among high-risk populations can inform mRNA booster-specific guidelines. The study emulated a target trial of COVID-19 vaccinated U.S.
J. Daniel Kelly +10 more
doaj +1 more source
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients [PDF]
Matthias Becker +19 more
openalex +1 more source
mRNA-1273 vaccination protects against SARS-CoV-2 elicited lung inflammation in non-human primates [PDF]
Adam T. Waickman +9 more
openalex +1 more source
Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients [PDF]
Alana F. Ogata +10 more
openalex +1 more source
Différences d’immunogénicité des vaccins anti-SRAS-CoV-2 mRNA-1273 (Moderna) et BNT162b2 (Pfizer-BioNTech) chez les patients dialysés [PDF]
Kevin Yau +21 more
openalex +1 more source
Multimodality imaging and histopathology in a young man presenting with fulminant lymphocytic myocarditis and cardiogenic shock after mRNA-1273 vaccination [PDF]
Mazhar Kadwalwala +3 more
openalex +1 more source
Bell's palsy as a possible complication of mRNA-1273 (Moderna) vaccine against COVID-19
Sujan Poudel +9 more
openalex +1 more source
Moderna (mRNA-1273) Covid-19 Vaccine, “A Systematic Review” [PDF]
A Global pandemic, declared by WHO, caused due to a deadly virus known as a “SARS-Cov-2”, has resulted in 4.3 million deaths. Its RNA based genome and lack of proofreading ability has made this virus more prone to get the frequent mutations and results ...
Abid, Sidra +3 more
core +1 more source
Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273 Vaccine
Abdulbaril Olagunju +5 more
openalex +1 more source
Correction to: mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients [PDF]
Nil Albiol +11 more
openalex +1 more source

